PDS Biotechnology Corporation (PDSB)
Operating Cash Flow (Statement)
-$16.78M
TTM · Period ending: · USD
PDSB Operating Cash Flow (Statement)
Latest reported-$16.78Mperiod ending
Latest reported-$16.78Mperiod ending
PDSB TTM Cash from Operations (-$21.75M → -$16.78M)
TTM operating cash flow (statement)
High-resolution chart · PNG
PDSB operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -16,782,788 | |
| -23,091,402 | |
| -27,752,012 | |
| -32,283,866 | |
| -34,367,505 | |
| -34,124,290 | |
| -35,030,223 | |
| -35,252,960 | |
| -34,429,203 | |
| -30,385,689 | |
| -33,636,136 | |
| -32,707,893 | |
| -31,424,869 | |
| -32,529,333 | |
| -25,709,706 | |
| -22,682,168 | |
| -21,917,967 | |
| -15,052,884 | |
| -12,486,066 | |
| -12,614,041 | |
| -8,737,396 | |
| -13,786,932 | |
| -13,149,135 | |
| -14,039,635 | |
| -17,115,575 | |
| -17,871,264 | |
| -18,073,870 | |
| -14,723,000 | |
| -19,559,000 | |
| -22,817,872 | |
| -33,152,872 | |
| -40,223,946 | |
| -42,458,946 | |
| -43,625,074 | |
| -40,697,074 | |
| -37,503,000 | |
| -34,897,000 | |
| -33,888,000 | |
| -32,188,000 | |
| -32,925,000 | |
| -29,131,000 | |
| -26,562,000 | |
| -21,753,000 | |
| -17,855,000 | |
| -15,461,000 |